| Literature DB >> 32731330 |
Guilherme Falcão Mendes1, Caio Eduardo Gonçalves Reis1, Eduardo Yoshio Nakano2, Teresa Helena Macedo da Costa1, Bryan Saunders3,4, Renata Puppin Zandonadi1.
Abstract
Caffeine is the world's most commonly used stimulant of the central nervous system. Caffeine is present in coffee and other beverages such as tea, soft drinks, and cocoa-based foods. The caffeine expectancy questionnaire was developed to investigate the effects of caffeine expectations and thus contribute to knowledge about its usage and subjective effects (response expectancies). This study aimed to evaluate caffeine expectation psychometrically in a sample of the Brazilian population. The original version of the "Caffeine Expectancy Questionnaire (CaffEQ)" was translated and validated into Brazilian-Portuguese and adapted to Brazilian culture to be used in the Brazilian adult (19-59 y) population. After the translation and back-translation processes of the original CaffEQ questionnaire, the content and semantic validation were performed by a group of experts. The Brazilian-Portuguese version of the questionnaire consists of 47 items, in seven factors, which assess subjective perceptions about the effects of caffeine. Interobserver reproducibility and internal consistency of the questionnaire were tested with a convenience sample (n = 50) of Brazilian adult consumers of caffeine sources, who completed the Brazilian CaffEQ (CaffEQ-BR) on two occasions separated by 24 h. All of the 47 questions were adequate regarding reliability, clarity, and comprehension. Psychometric properties could be replicated consistently. Appropriate internal consistency and validation were confirmed by Cronbach's alpha (α) 0.948, and an intraclass correlation coefficient of 0.976 was observed. The CaffEQ-BR was applied using a web-based platform to a convenience sample of Brazilian adults from all 27 Brazilian states (n = 4202 participants), along with measures of sociodemographic and caffeine consumption data. Factor validity was verified by confirmatory factor analysis. The seven factors presented a good fit for Root Mean Square Error of Approximation-RMSEA = 0.0332 (95% CI: 0.0290-0.0375). By confirming the validity and reliability of CaffEQ-BR, a useful tool is now available to assess caffeine expectations in the Brazilian adult population.Entities:
Keywords: Brazilian; Portuguese; caffeine; expectancy; instrument; subjective; validation
Year: 2020 PMID: 32731330 PMCID: PMC7468745 DOI: 10.3390/nu12082248
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flowchart of translation, cultural adaptation, semantic evaluation, content validation processes and application of the Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR).
Reproducibility and internal consistency of the instrument and factors of the Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR) *.
| Factors | N. Items | Internal Consistency | Reproducibility |
|---|---|---|---|
| Withdrawal/dependence | 12 | 0.948 (0.923–0.968) | 0.983 (0.969–0.991) |
| Energy/work enhancement | 8 | 0.926 (0.888–0.923) | 0.953 (0.912–0.975) |
| Appetite suppression | 5 | 0.872 (0.802–0.923) | 0.951 (0.903–0.974) |
| Social/mood enhancement | 6 | 0.889 (0.829–0.932) | 0.949 (0.900–0.973) |
| Physical performance enhancement | 3 | 0.924 (0.875–0.956) | 0.965 (0.936–0.981) |
| Anxiety/negative physical effects | 9 | 0.872 (0.807–0.921) | 0.953 (0.907–0.976) |
| Sleep disturbance | 4 | 0.941 (0.907–0.965) | 0.970 (0.945–0.983) |
|
|
|
|
|
* For reproducibility and internal consistency of items and factors of the CaffEQ-BR, conducted with a convenience sample of 50 Brazilian adults: 60% female, 36.4 ± 12.4 y, 62.2% of self- identification as white.
Figure 2National distribution of participants and average caffeine consumption. * As this is an external validation study of national scope, the sample calculation was performed according to the last Brazilian national census [38], with adequacy greater than or equal to 70% of the sample distribution according to the states of Brazil; ** caffeine in general sources. Northeast Region-Alagoas, Bahia, Ceará, Maranhão, Paraíba, Pernambuco, Piauí, Rio Grande do Norte, Sergipe; North Region-Acre, Amazonas, Amapá, Pará, Rondônia, Roraima, Tocantins; Midwest Region-Distrito Federal, Goiás, Mato Grosso, Mato Grosso do Sul; South Region-Paraná, Santa Catarina, Rio Grande do Sul; Southeast Region-Espírito Santo, Minas Gerais, Rio de Janeiro, São Paulo.
Sociodemographic data, sample profile of the CaffEQ-BR study (2019–2020).
| Categories | Total ( | ||
|---|---|---|---|
|
| % | ||
|
| Male | 2063 | 49.1 |
| Female | 2139 | 50.9 | |
|
| 19–24 | 822 | 19.5 |
| 25–30 | 755 | 18.0 | |
| 31–40 | 1331 | 31.7 | |
| 41–59 | 1294 | 30.8 | |
|
| <18.5 | 106 | 2.5 |
| 18.5–24.9 | 1751 | 41.7 | |
| 25–29.9 | 1498 | 35.6 | |
| ≥30 | 847 | 20.2 | |
|
| Asia descendants | 114 | 2.7 |
| White | 2328 | 55.4 | |
| Indigenous | 41 | 1.0 | |
| Pardo | 1330 | 31.6 | |
| Black | 309 | 7.4 | |
| Without description | 80 | 1.9 | |
|
| No | 1924 | 45.8 |
| Yes | 2278 | 54.2 | |
|
| No schooling | 3 | 0.1 |
| Incomplete elementary school | 17 | 0.4 | |
| Completed elementary school | 37 | 0.9 | |
| Incomplete high school | 101 | 2.4 | |
| Completed high school | 596 | 14.2 | |
| Incomplete higher education | 955 | 22.7 | |
| Higher education graduate | 1162 | 27.6 | |
| Postgraduate studies | 1315 | 31.3 | |
| Without description | 16 | 0.4 | |
|
| 1000.00 | 407 | 9.7 |
| 1000.01 to 2000.00 | 769 | 18.3 | |
| 2000.01 to 3000.00 | 669 | 15.9 | |
| 3000.01 to 5000.00 | 865 | 20.6 | |
| 5000.01 to 10,000.00 | 796 | 18.9 | |
| Above 10,000.00 | 575 | 13.7 | |
| Without description | 121 | 2.9 | |
|
| No | 3397 | 80.8 |
| Yes | 805 | 19.2 | |
* Body mass index (BMI) followed the criteria adopted by the World Health Organization (WHO) [39] underweight (BMI < 18.5 kg/m2), adequate (BMI between 18.5 and 24.9 kg/m2), overweight (BMI between 25 and 29.9 kg/m2) and obesity (BMI ≥ 30 kg/m2). ** 5.55 BRL = 1.00 USD on the last day of data collection, April 2020.
Distribution frequency of regular consumption of sources of caffeine per week (n = 4202).
| Caffeine Sources ¹ | Coffee 2 | Tea 3 | Chocolate 4 | Chocolate Beverages 5 | Soft Drinks 6 | Medication 7 | Energy Drinks 8 | Sports Supplements 9 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | ||
| Time of the Day | Early morning (00:00–06:00) | 202 | 4.8% | 79 | 1.9% | 153 | 3.6% | 70 | 1.7% | 149 | 3.5% | 115 | 2.7% | 109 | 2.6% | 19 | 0.5% |
| Morning (06:00–12:00) | 3853 | 91.7% | 503 | 12.0% | 644 | 15.3% | 653 | 15.5% | 362 | 8.6% | 505 | 12.0% | 188 | 4.5% | 333 | 7.9% | |
| Afternoon (12:00–18:00) | 2829 | 67.3% | 686 | 16.3% | 1594 | 37.9% | 523 | 12.4% | 1361 | 32.4% | 396 | 9.4% | 324 | 7.7% | 206 | 4.9% | |
| Evening (18:00–24:00) | 1508 | 35.9% | 878 | 20.9% | 1291 | 30.7% | 563 | 13.4% | 1058 | 25.2% | 699 | 16.6% | 348 | 8.3% | 122 | 2.9% | |
| N° of Servings Per Day | 1 | 971 | 23.1% | 1178 | 28.0% | 1647 | 39.2% | 908 | 21.6% | 985 | 23.4% | 824 | 19.6% | 530 | 12.6% | 463 | 11.0% |
| 2 | 1958 | 46.6% | 322 | 7.7% | 537 | 12.8% | 273 | 6.5% | 543 | 12.9% | 209 | 5.0% | 141 | 3.4% | 78 | 1.9% | |
| 3 | 983 | 23.4% | 92 | 2.2% | 235 | 5.6% | 89 | 2.1% | 209 | 5.0% | 111 | 2.6% | 43 | 1.0% | 19 | 0.5% | |
| 4 | 139 | 3.3% | 12 | 0.3% | 64 | 1.5% | 22 | 0.5% | 58 | 1.4% | 35 | 0.8% | 7 | 0.2% | 1 | 0.0% | |
| Total Recorded | 4051 | 96.4% | 1604 | 38.2% | 2483 | 59.1% | 1292 | 30.7% | 1795 | 42.7% | 1179 | 28.1% | 721 | 17.2% | 561 | 13.4% | |
1 Standardization of the portions in the consumption frequency table was adopted based on the dose of 50 mg of caffeine/portion. The percentages exceed 100% because consumption can occur in two or more periods. 2 Filtered or espresso, hot or iced coffee. 3 Tea sources of caffeine like mate, green and black tea. 4 Pure chocolate with ≥ 50% cocoa. 5 Chocolate beverages with ≥ 50% cocoa. 6 Cola nut or guarana based soft drinks. 7 Caffeinated medications. 8 Commercial drink sources of anhydrous caffeine or guarana extract beverage. 9 Sports supplements sources of anhydrous caffeine.
Correlations Between Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR) Factors and Caffeine-Related Variables (n = 4202).
| Sources | Factors of the CaffEQ-BR * | ||||||
|---|---|---|---|---|---|---|---|
| F1 | F2 | F3 | F4 | F5 | F6 | F7 | |
|
| 0.085 *** | 0.102 *** | 0.081 *** | 0.141 *** | 0.097 *** | 0.095 *** | −0.074 *** |
* Factors of the CaffEQ-BR: F1 Withdrawal/dependence; F2 Energy/work enhancement; F3 Appetite suppression; F4 Social/mood enhancement; F5 Physical performance enhancement; F6 Anxiety/negative physical effects; F7 Sleep disturbance; ** Caffeine in general sources (Tea, coffee, chocolate above 50% cocoa, chocolate beverages, cola nut or guarana based soft drinks, caffeinated drugs, commercial drinks and sports supplements sources of anhydrous caffeine or guarana extract beverage); Pearson correlation *** p < 0.001.
Mean and Standard Deviation (SD) of the scores on a six-point Likert scale of the seven factors of the Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR) by regions of Brazil (n = 4202).
| Regions ** | Factors of the CaffEQ-BR * Mean (SD) | ||||||
|---|---|---|---|---|---|---|---|
| F1 | F2 | F3 | F4 | F5 | F6 | F7 | |
| North | 3.48 (1.49) | 4.16 (1.37) | 2.21 (1.15) | 3.56 (1.45) | 3.49 (1.55) | 1.78 (0.69) | 2.51 (1.60) |
| Northeast | 3.44 (1.41) | 4.15 (1.31) | 2.24 (1.14) | 3.44 (1.38) | 3.55 (1.53) | 1.81 (0.77) | 2.45 (1.58) |
| Midwest | 3.34 (1.39) | 4.08 (1.32) | 2.13 (1.14) | 3.25 (1.34) | 3.50 (1.53) | 1.85 (0.82) | 2.62 (1.69) |
| Southeast | 3.60 (1.45) | 4.17 (1.33) | 2.26 (1.18) | 3.41 (1.38) | 3.47 (1.49) | 1.75 (0.75) | 2.44 (1.62) |
| South | 3.47 (1.43) | 4.08 (1.30) | 2.36 (1.24) | 3.42 (1.34) | 3.24 (1.48) | 1.74 (0.75) | 2.36 (1.57) |
| Brazil | 3.48 (1.43) | 4.14 (1.32) | 2.24 (1.17) | 3.41 (1.38) | 3.47 (1.51) | 1.78 (0.77) | 2.47 (1.62) |
* Factors of the CaffEQ-BR, range: 1.00–6.00: F1 Withdrawal/dependence; F2 Energy/work enhancement; F3 Appetite suppression; F4 Social/mood enhancement; F5 Physical performance enhancement; F6 Anxiety/negative physical effects; F7 Sleep disturbance. ** Regions of Brazil: North Region-Acre, Amazonas, Amapá, Pará, Rondônia, Roraima, Tocantins; Northeast Region-Alagoas, Bahia, Ceará, Maranhão, Paraíba, Pernambuco, Piauí, Rio Grande do Norte, Sergipe; Midwest Region-Distrito Federal, Goiás, Mato Grosso, Mato Grosso do Sul; South Region-Paraná, Santa Catarina, Rio Grande do Sul; Southeast Region-Espírito Santo, Minas Gerais, Rio de Janeiro, São Paulo.